We actively seek to acquire or license marketed products to grow our existing biodefense business and to
establish a commercial presence in other specialty markets. We seek:

 

• Approved specialty pharma products
• Currently procured biodefense products
• Biodefense products with a high likelihood of procurement
• Biodefense products with government funded development

 

Contact us at BD@ebsi.com.

 

 

We have more than 10 preclinical ADAPTIRTM (modular protein technology) mono-specific and multi-specific protein biotherapeutic candidates available for partnering. All our candidates have in vitro data and most include in vivo data and manufacturing proof of concept.

 

ADAPTIR—mono-specific protein biotherapeutic preclinical programs in oncology & autoimmunity.
LEARN MORE

 

ADAPTIR—multi-specific protein biotherapeutic preclinical programs in oncology & autoimmunity.
LEARN MORE

 

 

 

Government Relationships
Government Agency Product Product Candidates 

U.S. Department of Health and Human Services (DHHS)
National Institute of Allergy and Infectious Diseases (NIAID)
Biomedical Advanced Research and Development Authority (BARDA)
BioThrax®
(Anthrax Vaccine Adsorbed)

NuThraxTM
(Anthrax Vaccine Adsorbed with CPG 7909 Adjuvant)
  PreviThraxTM
(Recombinant Protective Antigen Anthrax Vaccine, Purified)
  ThravixaTM
(Fully Human Anthrax Monoclonal Antibody)
  AnthrivigTM
(Human Anthrax Immunoglobulin)
Centers for Disease Control (CDC) BioThrax®
(Anthrax Vaccine Adsorbed)		  
U.S. Department of Defense (DoD)


Joint Program Executive Office Chemical and Biological Medical Systems (JPEO-CBMS)		 BioThrax®
(Anthrax Vaccine Adsorbed)		  

 

Submit your inquiry! BD@ebsi.com

MEET US

  • Business Development

    PWC - The Biopharmaceutical Conference in Europe
    June 19 - 21
    Divonne Les Bains, France

  • BioSciences

    Phacilitate - Partnering for Vaccine Emerging Markets
    June 10 - 12
    Berlin, Germany

  • Investor Relations

    Janney Healthcare Conference
    6/27/13
    New York, New York

  • Biodefense

    11th Annual Emerging Infectious Diseases & Biodefense
    June 17 - 19
    Washington, DC

  • BioSciences

    18th Congress of EHA
    June 13 - 16
    Stockholm, Sweden

© 2012 Emergent BioSolutions Inc. All rights reserved. ABOUT | PRODUCT | PIPELINE | PARTNERING | INVESTORS | CAREERS | NEWSROOM | CONTACT US | TERMS OF USE | PRIVACY POLICY